je.st
news
Endo To Purchase Par Pharmaceutical
2015-05-19 10:32:25| Biotech - Topix.net
Endo , a specialty drug firm based in Ireland, will pay $8.1 billion in cash and stock to acquire the U.S.-based generic drug firm Par Pharmaceutical . The combined business will have about $4.2 billion in annual sales.
Tags: par
purchase
pharmaceutical
endo
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||